MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mej.0000000000000932

Медицинская библиотека · European journal of emergency medicine : official journal of the European Society for Emergency Medicine · 2022

Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs.

Heier Eva-Carina, Eyer Florian, Rabe Christian, Geith Stefanie, Dargan Paul I, Wood David M, Heyerdahl Fridtjof, Dines Alison M, Giraudon Isabelle, Erik Hovda Knut, Yates Chris, Vallersnes Odd Martin, Miró Òscar, Liechti Matthias E, Zellner Tobias, Euro-DEN Research Group

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND AND

IMPORTANCE

Patients who use recreational drugs frequently co-ingest ethanol, which is considered a central nervous system (CNS) depressant. The clinical relevance of this in acute toxicity involving other CNS depressants is not well described.

OBJECTIVE

To assess the clinical impact of ethanol co-use in patients presenting to the emergency department (ED) with acute toxicity involving the use of CNS depressant drugs.

DESIGN, SETTINGS AND

PARTICIPANTS

A retrospective multicentre study using data from the Euro-DEN Plus database from January 2014 to December 2019.

OUTCOMES MEASURE AND ANALYSIS: Comparison of epidemiologic and clinical characteristics, ED and hospital management of patients with CNS depressant intoxication with or without ethanol co-use.

MAIN

RESULTS

Although 7644 (17.5%) of the 43 633 presentations were included, ethanol was co-ingested in 3811 (49.9%). In total 53.3% required medical treatment, 14 patients died. Patients with ethanol co-use more frequently presented with a Glasgow Coma Scale (GCS) ≤8 (34.1% vs. 22.4%; P   <  0.001), vomiting (8.1% vs. 4.6%; P   <  0.001), anxiety (12 % vs. 6.4%; P   <  0.001), agitation/aggression (22% vs. 14.7%; P   <  0.001), seizures (3.8% vs. 2.4%; P   <  0.001) and hypotension (7.5% vs. 4.6%; P   <  0.001). They more often required ambulance transport (85.5% vs. 76.5%; P   <  0.001), medical treatment (57.3% vs. 48.0%; P   <  0.001), hospitalization (27.7% vs. 18.9%; P   <  0.001), and admission to intensive care (12.2% vs. 4.0%; P   <  0.001). Subgroup analysis showed that GCS ≤8 was particularly common in patients who combined ethanol with opioids or gamma-hydroxybutyrate (GHB)/gamma-butyrolactone (GBL).

CONCLUSION

Co-use of ethanol with CNS-depressant drugs appears to increase the risk of adverse effects and is associated with a higher need for medical treatment, especially when ethanol is combined with opioids or GHB/GBL.

Для цитирования: Heier Eva-Carina, Eyer Florian, Rabe Christian, Geith Stefanie, Dargan Paul I, Wood David M, Heyerdahl Fridtjof, Dines Alison M, Giraudon Isabelle, Erik Hovda Knut, Yates Chris, Vallersnes Odd Martin, Miró Òscar, Liechti Matthias E, Zellner Tobias, Euro-DEN Research Group. Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs.. European journal of emergency medicine : official journal of the European Society for Emergency Medicine. 2022. DOI: 10.1097/mej.0000000000000932.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.